BioSpace News Archive

Continuing medical education has been one of the crucial parts of the healthcare industry. Health care professionals need to keep themselves up-to-date with changes in the medical field and treatment options relevant to their area of expertise.

Fact.MR – A Market Research and Competitive Intelligence Provider: As per the latest survey conducted by Fact.MR, the global arthroscopy products market is poised to reach US$ 6.2 billion in 2021.

IRADIMED CORPORATION (NASDAQ: IRMD) announced today that the Company will release its 2021 third quarter financial results before the market opens on Friday, October 29th .

Hyloris Pharmaceuticals SA announces that it has acquired the global rights from the Baker Heart and Diabetes Institute, Melbourne, Australia, to CRD-102, a novel, clinical-stage, extended-release Milrinone capsule in late-stage heart failure patients with an implanted left ventricular assist device who have developed right HF.

According to the report, the global short bowel syndrome market was valued at US$ 728.3 Mn in 2020 and is projected to expand at a CAGR of 15.9% from 2021 to 2031.

The high pressure contrast media injectors market is growing rapidly with an increase in chronic conditions such as neurovascular, cardiovascular, and cancer.

The antibody drug conjugates market is anticipated to gain promising growth across the assessment period of 2020-2030 owing to the heightening prevalence of cancer around the world.

Ambulance services are vital for transportation in case of medical emergencies. Efficient ambulance services has led to on-time medical attention for accident victims or patients with chronic illness, emergency medication situations, etc.

AsclepiX Therapeutics, Inc., a clinical stage biopharmaceutical company using computational biology to identify potent peptide regulators of vascular and cellular homeostasis for the treatment of retinal and oncologic diseases, announced the appointment of Dr. Amir Shojaei as Chief Scientific Officer, Executive Vice President, Clinical Development.

Lucira Health, Inc., a medical technology company focused on the development and commercialization of transformative and innovative infectious disease test kits, commented on the recent recall of the FLOQSwabs by supply partner Copan Italia SPA, or Copan.